Folgen
Tihana Bicanic
Titel
Zitiert von
Zitiert von
Jahr
Cryptococcal meningitis
T Bicanic, TS Harrison
British medical bulletin 72 (1), 99-118, 2004
5922004
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10285), 1637-1645, 2021
460*2021
Cryptococcus: from environmental saprophyte to global pathogen
RC May, NRH Stone, DL Wiesner, T Bicanic, K Nielsen
Nature Reviews Microbiology 14 (2), 106-117, 2016
3962016
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
NRH Stone, T Bicanic, R Salim, W Hope
Drugs 76, 485-500, 2016
3542016
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
MedRxiv, 2021.06. 15.21258542, 2021
342*2021
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes
JN Jarvis, T Bicanic, A Loyse, D Namarika, A Jackson, JC Nussbaum, ...
Clinical infectious diseases 58 (5), 736-745, 2014
3392014
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or …
T Bicanic, G Meintjes, R Wood, M Hayes, K Rebe, LG Bekker, T Harrison
Clinical infectious diseases 45 (1), 76-80, 2007
3282007
Antifungal combinations for treatment of cryptococcal meningitis in Africa
SF Molloy, C Kanyama, RS Heyderman, A Loyse, C Kouanfack, ...
New England Journal of Medicine 378 (11), 1004-1017, 2018
2872018
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.
JN Jarvis, G Meintjes, K Rebe, GN Williams, T Bicanic, A Williams, ...
AIDS (London, England) 26 (9), 1105, 2012
2772012
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial
T Bicanic, R Wood, G Meintjes, K Rebe, A Brouwer, A Loyse, LG Bekker, ...
Clinical infectious diseases 47 (1), 123-130, 2008
2762008
Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution
T Bicanic, T Harrison, A Niepieklo, N Dyakopu, G Meintjes
Clinical Infectious Diseases 43 (8), 1069-1070, 2006
2592006
Cryptococcosis diagnosis and treatment: What do we know now
JR Perfect, T Bicanic
Fungal Genetics and Biology 78, 49-54, 2015
2582015
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10274), 605, 2021
2512021
The case for adopting the “species complex” nomenclature for the etiologic agents of cryptococcosis
KJ Kwon-Chung, JE Bennett, BL Wickes, W Meyer, CA Cuomo, ...
MSphere 2 (1), e00357-16, 2017
2312017
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients
T Bicanic, C Muzoora, AE Brouwer, G Meintjes, N Longley, K Taseera, ...
Clinical infectious diseases 49 (5), 702-709, 2009
2302009
Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study
T Bicanic, G Meintjes, K Rebe, A Williams, A Loyse, R Wood, M Hayes, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (2), 130-134, 2009
2252009
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures
T Bicanic, AE Brouwer, G Meintjes, K Rebe, D Limmathurotsakul, ...
Aids 23 (6), 701-706, 2009
2062009
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
A Loyse, H Thangaraj, P Easterbrook, N Ford, M Roy, T Chiller, ...
The Lancet infectious diseases 13 (7), 629-637, 2013
1742013
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the …
A Loyse, D Wilson, G Meintjes, JN Jarvis, T Bicanic, L Bishop, K Rebe, ...
Clinical infectious diseases 54 (1), 121-128, 2012
1552012
Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis
W Sabiiti, E Robertson, MA Beale, SA Johnston, AE Brouwer, A Loyse, ...
The Journal of clinical investigation 124 (5), 2000-2008, 2014
1352014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20